Pls refer the attachment

Related Party TransactionsResults View source PDF Explain this filing

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.5%Reaction day

₹1208.00

prior close

₹1269.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%+5.4% vs market

Healthcare Service Provider peers, median of 27sector+1.5%+4.1% vs sector

On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.4

10m

-2.7

15m

-2.5

30m

-2.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.5+0.2+5.4+1.5+4.1

Next day

+10.1-0.9+11.0+1.6+8.5

+6.0-3.9+9.9-0.2+6.2

+7.0-3.6+10.6+0.0+7.0

+6.0-3.6+9.5+1.2+4.8

+11.3-3.9+15.2-0.5+11.8

+8.0-4.3+12.3-0.2+8.2

15d

+3.4-3.2+6.6+0.7+2.7

+8.1-3.8+11.9-1.0+9.1

+10.1+1.1+9.0-3.1+13.2

+15.5+5.4+10.2-3.6+19.2

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vijaya Diagnostic Centre Limited's Board approved audited standalone and consolidated financial results for Q4 and year ended March 31, 2026. The Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1) for FY2026, subject to shareholder approval at the AGM. Dr. D Nageshwar Reddy will not seek re-appointment for a second term as Independent Director effective May 25, 2026, citing pre-occupation and other professional commitments. The company granted 1,79,500 ESOPs to eligible employees at an exercise price of ₹784 per option (20% discount to 3-month average price). Additionally, the Board approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore, consolidating diagnostic services operations.

Likely market impact

The dividend declaration and ESOP grants signal management confidence in the company's financial health. The acquisition of diagnostic services business from the WOS at ₹4.20 crore is a strategic consolidation move that may streamline operations and improve profitability of the diagnostic chain.